Inspire Medical Systems, Inc.

NYSE:INSP

Medical - Devices

Healthcare
$58.11 +1.24%

+$0.51 today

Market cap
$1.68B
Beta
0.73
P/E (TTM)
9.1
EPS (TTM)
$4.57
52W Low $38.91High $147.03

Volume 0.51M

Average 1.13M

INSP Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Inspire Medical Systems, Inc.NYSE: INSP

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 85.5%

Gross margin was 85.5% in Q2 FY2026, up 1.5 pp from a year earlier. On a trailing-twelve-month basis it was 86.1%, up 1.7 pp year over year. Over 3 fiscal years it widened by 1.6 pp.

Context

  • Gross margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
85.5%-1.0 pp QoQ
Last fiscal yearDec 2025
85.4%+0.7 pp YoY
LTMJun 2026
86.1%+1.7 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.5 pp——
1 year+0.7 pp——
3 years+1.6 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
85.4%
Year-over-year change
+0.7pp

Gross Margin vs competitors

How INSP compares with its peers on the latest reported figures

  • INSP's LTM Jun 2026 gross margin of 86.1% is the 2nd highest of the 9 companies compared; the peer median is 56.3%.
  • Its year-over-year change of +1.7 pp is the 2nd highest of 9, against a peer median of -1.1 pp.
  • Over three fiscal years its change of +1.6 pp compares with a peer median of +1.4 pp.
INSP Competitors Peer median
Gross Margin for INSP and competitors
Company Period LTM level YoY 3-year change
RCUSArcus Biosciences, Inc.LTM Jun 202694.0% -6.0 pp-4.0 pp
INSPInspire Medical Systems, Inc.LTM Jun 202686.1% +1.7 pp+1.6 pp
LMATLeMaitre Vascular, Inc.LTM Mar 202672.4% +3.6 pp+6.6 pp
PRCTPROCEPT BioRobotics CorporationLTM Mar 202663.0% +0.3 pp+14.3 pp
AORTArtivion, Inc.LTM Mar 202662.9% -1.0 pp-3.3 pp
ARDTArdent Health Partners, LLCLTM Mar 202649.7% -26.6 pp+16.2 pp
ADUSAddus HomeCare CorporationLTM Jun 202632.4% -0.2 pp+1.0 pp
ITGRInteger Holdings CorporationLTM Jul 202623.7% -1.3 pp-3.0 pp
BKDBrookdale Senior Living Inc.LTM Sep 202614.5% -12.7 pp+1.9 pp
Peer median (excluding INSP) 56.3%-1.1 pp+1.4 pp

Competitors are the stored peer set for INSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue233.39M407.86M624.8M802.8M911.98M
Cost of Revenue33.28M66.12M96.58M122.99M133.23M
Gross Profit200.12M341.74M528.22M679.82M778.76M
Gross Margin85.7%83.8%84.5%84.7%85.4%
Research & Development37.35M68.65M116.54M114.13M103.17M
Selling, General & Admin202.62M320.69M451.96M529.61M624.64M
Operating Expenses239.97M389.33M568.49M643.74M727.8M
Depreciation & Amortization1.22M1.86M2.85M6.55M13.96M
EBITDA(38.62M)(40.73M)(17.06M)65.03M79.79M
EBITDA Margin-16.5%-10.0%-2.7%8.1%8.7%
Operating Income(39.85M)(47.59M)(40.27M)36.08M50.95M
Operating Margin-17.1%-11.7%-6.4%4.5%5.6%
Interest Income125K5.05M20.56M23.25M17.54M
Interest Expense2.13M1.68M022K137K
Other Income / Expenses(2.12M)3.32M20.37M22.37M14.74M
Income Before Tax(41.97M)(44.27M)(19.91M)58.45M65.7M
Pre-Tax Margin-18.0%-10.9%-3.2%7.3%7.2%
Income Tax Expense72K613K1.25M4.94M(79.73M)
Net Income(42.04M)(44.88M)(21.15M)53.51M145.42M
Net Margin-18.0%-11.0%-3.4%6.7%15.9%
EPS (Basic)(1.54)(1.60)(0.72)1.804.95
EPS (Diluted)(1.54)(1.60)(0.72)1.754.89
Weighted Avg Shares27.26M28.07M29.3M29.76M29.37M
Weighted Avg Shares (Diluted)27.26M28.07M29.3M30.54M29.76M

Inspire Medical Systems, Inc.

NYSE:INSP

Intrinsic Alpha fair value

Locked

Current Price

$58.11

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.